Emami Capital Structure Change
Emami Limited bought back 8,00,000 equity shares on September 24, 2026, at an average price of ₹391.75. The cumulative shares bought back under this program total 20,17,000.
- Value
- ₹31.34 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements with these filters
Emami Limited bought back 8,00,000 equity shares on September 24, 2026, at an average price of ₹391.75. The cumulative shares bought back under this program total 20,17,000.
Emami Ltd bought back 8.47 lakh equity shares for ₹34.17 Crore via the open market on September 23, 2026.
Emami Limited bought back 3,70,000 equity shares at an average price of ₹388.48 per share, totaling ₹14.37 Crore.
Emami Ltd's board approved a share buyback of up to ₹282.00 Crore via open market. The company will repurchase 5,936,842 equity shares at ₹475.00 per share.
Emami's Board approved an open-market buyback of up to 5,936,842 shares at ₹475 each. Maximum buyback size is ₹282 Crore from public shareholders.
Emami Limited has scheduled a board meeting for September 17, 2026, to consider a proposal for the buyback of its fully paid-up equity shares.
Promoter entities Diwakar Finvest and Suraj Finvest disclosed multiple pledge creations and releases involving shares of Emami Ltd between August 28 and September 02, 2026.
Emami Q1FY27 reported 15% consolidated revenue growth to ₹1,039 cr. Domestic growth at 20% (12% like-to-like) driven by Hair Care and strategic investments like Axiom and IncNut.
Emami reported Q1FY27 consolidated revenue growth of 15% YoY with an EBIDTA margin of 21.8%. The company is transitioning to category-led reporting to reflect its diversified portfolio.
Emami Ltd reported revenue from operations of ₹1,039 Cr (+14.9% YoY) and net profit of ₹138.9 Cr (-15.5% YoY) for Q1 FY27.
Emami Limited Q4 FY26 revenue declined 4% to ₹925cr due to a weak summer, despite gross margin expansion to 68.4%. Management remains confident for FY27.
Emami Limited's FY26 results reflect a challenging year with consolidated revenues down 1%, impacted by unfavorable seasonality and a 16% decline in summer portfolios.
Emami's Q4FY26 was impacted by seasonal headwinds and West Asia geopolitical conflict, yet domestic non-summer portfolio grew 11%. Strategic acquisitions in Axiom Ayurveda and IncNut aim for future growth.
Emami Ltd reported revenue from operations of ₹925.1 Cr (-3.9% YoY) and net profit of ₹143.2 Cr (-11.7% YoY) for Q4 FY26.